Debate on Progesterone Elevation on the Day of Triggering
PE
The Neverending Debate on Progesterone Elevation: Possible Solutions
1 other identifier
observational
8,000
1 country
1
Brief Summary
The association between serum progesterone (P) levels, measured on the day of ovulation trigger, and the outcome of in vitro fertilization cycles, has been one of the major controversies in the field of ovarian stimulation endocrinology. This is a single-center retrospective cohort study. Study duration period is from January 2012 to December 2016. All fresh embryo transfer (ET) both at cleavage stage and blastocyst stage, performed in Humanitas Fertility Center during the study period, were included.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedFirst Submitted
Initial submission to the registry
January 31, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedFebruary 5, 2020
January 1, 2020
5 years
January 31, 2020
January 31, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Impact of PE on CPR and LBR
To evaluate the impact of premature high serum P levels on the outcome of fresh embryo transfer cycles in terms of Clinical Pregnancy Rates (CPR) and Live Birth Rates (LBR).
January 2012-December 2016
Secondary Outcomes (1)
Blastocyst embryo transfers' outcomes in PE
January 2012-December 2016
Study Arms (2)
cleavage stage embryo
embryo which is on day 2 or 3
blastocyst embryo
embryo which is on day 5
Interventions
Step of the assisted reproduction in which embryos are placed into the uterus in order to obtain a pregnancy
Eligibility Criteria
All fresh embryo transfers both at cleavage stage (Day 2 and Day3) and blastocyst stage (Day 5), and all thawed embryo transfer, except from the ones deriving from PGTA, performed from January 2012 to December 2016 in Humanitas Fertility Center were included.
You may qualify if:
- All fresh embryo transfers both at cleavage stage (Day 2 and Day3) and blastocyst stage (Day 5)
- Thawed embryo transfer deriving from supernumerary embryos cycles, by P increase, by OHSS, by other reasons (i.e inadequate endometrium, medical complications, etc)
You may not qualify if:
- thawed embryo transfers deriving from PGTA.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Paolo Emanuele Levi Setti
Rozzano, MI, 20089, Italy
Related Publications (1)
De Cesare R, Morenghi E, Cirillo F, Ronchetti C, Canevisio V, Persico P, Baggiani A, Sandri MT, Levi-Setti PE. The Role of hCG Triggering Progesterone Levels: A Real-World Retrospective Cohort Study of More Than 8000 IVF/ICSI Cycles. Front Endocrinol (Lausanne). 2020 Sep 23;11:547684. doi: 10.3389/fendo.2020.547684. eCollection 2020.
PMID: 33071968DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raffaella De Cesare
Humanitas clinical and research hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2020
First Posted
February 5, 2020
Study Start
January 1, 2012
Primary Completion
December 31, 2016
Study Completion
October 1, 2019
Last Updated
February 5, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share